Literature DB >> 23213138

Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1.

Frank Chen1, Ayantika Ghosh, Benjamin L Shneider.   

Abstract

Functional defects in ATPase class I type 8B membrane 1 (ATP8B1 or familial intrahepatic cholestasis 1, FIC1) lead to cholestasis by mechanism(s) that are not fully understood. One proposed pathophysiology involves aberrant signaling to the bile acid sensor, the farnesoid X receptor (FXR), via protein kinase C ζ (PKCζ). The following cell line-based studies investigated whether phospholipase D2 may transduce a signal from FIC1 to FXR. PLD2 gain of function led to activation of the bile salt export pump (BSEP) promoter, a well-characterized FXR response. BSEP activation by PLD2 could be blocked by abrogating either PKCζ or FXR signaling. PLD2 loss of function led to a reduction in BSEP promoter activity. In addition, a variety of proteins that are activated by FXR, including BSEP, were reduced in HepG2 cells treated with PLD2 siRNA. Similar effects were observed in freshly isolated human hepatocytes. Activation of BSEP by FIC1 gain of function was blocked when PLD2 but not PLD1 was silenced. Overexpression of wild-type but not Byler mutant FIC1 led to an increase in membrane associated PLD activity. An intermediate level of activation of PLD activity was induced when a benign recurrent intrahepatic cholestasis FIC1 mutant construct was expressed. These studies show that FIC1 signals to FXR via a signaling pathway including PLD2 and PKCζ.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23213138      PMCID: PMC3588867          DOI: 10.1194/jlr.M030304

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  49 in total

1.  Focus on molecules: Phospholipase D.

Authors:  Wanwen Lan; Louis Tong
Journal:  Exp Eye Res       Date:  2011-11-22       Impact factor: 3.467

2.  Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Authors:  Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Karan Emerick; Anthony Antoniou; Catherine Wanty; Bjorn Fischler; Emmanuel Jacquemin; Sami Wali; Samra Blanchard; Inge-Merete Nielsen; Billy Bourke; Shirley McQuaid; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Leo Klomp; Roderick Houwen; Peter Bacchetti; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Benjamin Shneider; Antal Nemeth; Etienne Sokal; Nelson B Freimer; A S Knisely; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson; Laura N Bull
Journal:  J Hepatol       Date:  2010-04-13       Impact factor: 25.083

Review 3.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 4.  Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners.

Authors:  Jin-Hyeok Jang; Chang Sup Lee; Daehee Hwang; Sung Ho Ryu
Journal:  Prog Lipid Res       Date:  2011-12-28       Impact factor: 16.195

5.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Authors:  B Goodwin; S A Jones; R R Price; M A Watson; D D McKee; L B Moore; C Galardi; J G Wilson; M C Lewis; M E Roth; P R Maloney; T M Willson; S A Kliewer
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

6.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.

Authors:  T T Lu; M Makishima; J J Repa; K Schoonjans; T A Kerr; J Auwerx; D J Mangelsdorf
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

7.  Biochemical characterization of P4-ATPase mutations identified in patients with progressive familial intrahepatic cholestasis.

Authors:  Alex Stone; Christopher Chau; Christian Eaton; Emily Foran; Mridu Kapur; Edward Prevatt; Nathan Belkin; David Kerr; Torvald Kohlin; Patrick Williamson
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

8.  Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1.

Authors:  Dineke E Folmer; Vincent A van der Mark; Kam S Ho-Mok; Ronald P J Oude Elferink; Coen C Paulusma
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

9.  Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia.

Authors:  Nancy B Ray; Lakshmi Durairaj; Bill B Chen; Bryan J McVerry; Alan J Ryan; Michael Donahoe; Alisa K Waltenbaugh; Christopher P O'Donnell; Florita C Henderson; Christopher A Etscheidt; Diann M McCoy; Marianna Agassandian; Emily C Hayes-Rowan; Tiffany A Coon; Phillip L Butler; Lokesh Gakhar; Satya N Mathur; Jessica C Sieren; Yulia Y Tyurina; Valerian E Kagan; Geoffrey McLennan; Rama K Mallampalli
Journal:  Nat Med       Date:  2010-09-19       Impact factor: 53.440

10.  ATPase Class I Type 8B Member 1 and protein kinase C zeta induce the expression of the canalicular bile salt export pump in human hepatocytes.

Authors:  Frank Chen; Ewa Ellis; Stephen C Strom; Benjamin L Shneider
Journal:  Pediatr Res       Date:  2010-02       Impact factor: 3.756

View more
  5 in total

1.  c-Fos mediates repression of the apical sodium-dependent bile acid transporter by fibroblast growth factor-19 in mice.

Authors:  Ayantika Ghosh; Frank Chen; Swati Banerjee; Ming Xu; Benjamin L Shneider
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-05       Impact factor: 4.052

2.  Modulation of Insulin Sensitivity of Hepatocytes by the Pharmacological Downregulation of Phospholipase D.

Authors:  Nataliya A Babenko; Vitalina S Kharchenko
Journal:  Int J Endocrinol       Date:  2015-05-24       Impact factor: 3.257

3.  Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.

Authors:  Amanda R Noble; Norman J Maitland; Daniel M Berney; Martin G Rumsby
Journal:  Br J Cancer       Date:  2017-11-14       Impact factor: 7.640

4.  An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy.

Authors:  Peter H Dixon; Melissa Sambrotta; Jennifer Chambers; Pamela Taylor-Harris; Argyro Syngelaki; Kypros Nicolaides; A S Knisely; Richard J Thompson; Catherine Williamson
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

5.  Two novel ATP8B1 mutations involved in progressive familial intrahepatic cholestasis type 1 that is ameliorated by rifampicin: A case report.

Authors:  Yan Huang; Er Ping Luo; Min Li; Jing Yang; Jian He Gan; Wei Feng Zhao
Journal:  J Dig Dis       Date:  2022-02-22       Impact factor: 3.366

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.